Interleukin-2, a cytokine that helps the immune system fight disease, is an FDA-approved treatment, but it has been associated with selectivity, toxicity and dosing issues. Those shortcomings have inspired a wave of biotechs trying to create the next generation of IL-2 therapies. Now, Rice University researchers say they did so using beadlike implants. In a […]

Ampio Pharmaceuticals (NYSE American:AMPE), citing a significant impact from COVID-19 on its second confirmatory Phase 3 trial of Ampion for the treatment of severe osteoarthritis of the knee (OAK), hopes to meet with the FDA in the first half of 2022 to discuss a proposed modified intent-to-treat efficacy analysis for AP-013, its second pivotal trial. “We […]

As the Ukraine crisis intensifies, CFOs across industries have been scrambling to keep up with fast-changing sanctions against Russia, assess and manage their corporate risk and make sure they have hardened defenses against the increased threats of cyber attacks. The financial fallout is gaining momentum. The U.S. and a coalition of G-7 nations joined together […]